Peripheral neuropathy decisions — 2022

The Veteran's claims of service connection for kidney cancer, left lower extremity neuropathy secondary to diabetes mellitus II, and right lower extremity neuropathy secondary to diabetes mellitus II have been reopened due to the submission of new and material evidence. The appeal is granted.,The Veteran's PTSD has been rated at 70 percent.

The Board has remanded the claims for service connection due to issues with the Veteran's mailing address and for additional VA examinations.

The Board has dismissed the appeal due to the appellant's withdrawal of all issues currently on appeal.

The Veteran's claims for increased ratings for bilateral lower extremity peripheral neuropathy of the femoral nerves prior to March 30, 2016 have been granted.,An earlier effective date for the award of 20 percent ratings for bilateral lower extremity peripheral neuropathy (femoral nerves) is denied.

The Veteran is seeking compensation under 38 U.S.C. § 1151 for CIDP, a condition he developed as a result of taking VA-prescribed Leflunomide. The Board has determined that further medical examination and opinion are needed to determine if the additional disability was caused by VA's carelessness or negligence.

The Board has remanded the Veteran's claims for HIV and related complications, as well as his claim for dental treatment purposes due to HIV. The AOJ is instructed to verify the exact dates of each period of active duty, inactive duty training, and reserve service that the Veteran attended after May 1987.

The Board has determined that additional development is needed for the Veteran's claims, including a VA examination to assess the current severity of his service-connected diabetic neuropathy and hearing loss/tinnitus. The issues have been remanded.

The Board has granted service connection for right upper, left upper, right lower, and left lower extremity peripheral neuropathy as a result of exposure to herbicides (Agent Orange). The evidence supports the conclusion that these conditions are related to the Veteran's in-service exposure.

The Board has granted service connection for diabetes mellitus, type II and hypertension due to herbicide exposure. Service connection for peripheral neuropathy is remanded as the Veteran's early-onset peripheral neuropathy did not manifest within one year of presumed herbicide exposure.

The Veteran's diabetes mellitus type I is rated at 60 percent since January 16, 2020. The rating is denied as the evidence does not meet the criteria for a higher evaluation.

The Board denied the Veteran's claim for service connection for bilateral upper extremity peripheral neuropathy, finding that there is no current diagnosis of this condition.

The Veteran's diabetes and diabetic peripheral neuropathy are granted as due to presumed herbicide exposure, with service connection established for both conditions.

The Board has found that the Veteran does not have a current disability for which service connection is warranted, and therefore denied her claims. The cases are remanded for further examination and opinion.

The Veteran's right knee and back disorders are found to be proximately due to his service-connected left knee disability.,Service connection for radiculopathy of the LLE is reopened based on new evidence.

The Veteran's hypertension is granted as service connected due to herbicide exposure.,Obstructive sleep apnea is granted as secondary to PTSD. The Veteran's RLE and LLE sciatic diabetic neuropathy are each rated at 20%.,Erectile dysfunction is not granted a higher rating.

The Veteran's service connection claims for impaired fasting glucose, ischemic heart disease, peripheral neuropathy of the upper and lower extremities, cataracts, vitreous degeneration, right knee disability, left foot and right foot plantar fasciitis, IBS, diverticulosis, cholelithiasis, inguinal hernia, prostate enlargement, hypertrophy of the prostate, kidney cyst, microscopic hematuria, thick walled bladder, esophagitis, eosinophilic esophagitis, and stricture and stenosis of esophagus have all been denied.,The Veteran's service connection claims are not supported by evidence showing a current disability or a relationship to service.

The Veteran's hypertension is granted as secondary to his service-connected diabetes mellitus II. The peripheral neuropathy of the bilateral hands and feet are remanded for further review.

The Board has remanded the Veteran's claims for additional development due to outstanding records and consideration of all evidence since the October 2016 Statement of the Case.

The Veteran's appeal for service connection for prostate carcinoma, peripheral neuropathy, and a heart disorder including ischemic heart disease has been dismissed as the Veteran opted into the modernized appeals system.

An increased 40 percent disability rating for right lower extremity peripheral neuropathy of the sciatic nerve is granted from February 11, 2016 onward.,A disability rating in excess of 10 percent for right lower extremity peripheral neuropathy of the anterior crural nerve is denied prior to January 4, 2019. A 20 percent disability rating is granted from January 4, 2019 onward for right lower extremity peripheral neuropathy of the external popliteal nerve.